Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the period ended December 31, 2020. For a further discussion of our Risk Factors, refer to the “Risk Factors” discussion contained in our Annual Report on Form 10-K for the year ended December 31, 2020.
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Period | Total number of shares purchased (000s) | Average price paid per share | Total number of shares purchased as part of Authorization (000s) | Approximate dollar value of shares still available to be purchased under the Authorization (000s) | ||||||||||||||||||||||
| July 1 - July 31 | 94 | $ | 138.31 | 94 | $ | 401,445 | ||||||||||||||||||||
| August 1 - August 31 | — | — | — | 401,445 | ||||||||||||||||||||||
| September 1 - September 30 | — | — | — | 401,445 | ||||||||||||||||||||||
| Total | 94 | $ | 138.31 | 94 | $ | 401,445 |
On February 6, 2020, our Board of Directors approved a share repurchase authorization of up to, and including, $800 million of the Company’s ordinary shares (the "2020 Share Repurchase Authorization"). The 2020 Share Repurchase Authorization does not have a prescribed expiration date. Based on market conditions, share repurchases are made from time to time in the open market at the discretion of management.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits